A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer treatment without chemotherapy.
Colorectal cancer is rising in adults under 50. In response, UCSF is launching a new Young-Onset Colorectal Cancer Program designed to meet the distinct medical and life-stage needs of younger patients.
UCSF researchers calculated the annual cost of using sunscreens and found huge variations, depending on product price and how much skin a person exposes to the sun.
Led by Jim Wells, PhD, researchers at UCSF have discovered that abnormal protein fragments produced inside cancer cells can appear on the cell surface, offering a distinctive marker that could help guide antibody-based therapies directly to tumors.
Eleven investigators and teams were awarded grants in support of cancer research projects in the fall 2025 cycle of the UCSF Resource Allocation Program (RAP).
A recent study led by George F. Sawaya, MD, a UCSF professor of Obstetrics, Gynecology and Reproductive Sciences and Epidemiology & Biostatistics, found many women 21-49 years old strongly preferred a self-collected HPV test.
Though investments in partnerships and innovation, advances in targeted treatments and screening recommendations, our cancer community remained dedicated to not only treat cancer — but to prevent it, and to ensure that all communities benefit from scientific progress.
A pioneering study has found that an individualized approach to breast cancer screening that assesses patients’ risk, rather than annual mammograms, can lower the chance of more advanced cancers, while still safely match people to the amount of screening they need.